ASP Isotopes (ASPI) Competitors $7.52 +0.08 (+1.08%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$7.55 +0.03 (+0.40%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASPI vs. CC, NGVT, UAN, BAK, ECVT, TROX, WLKP, ASIX, OEC, and VHIShould you be buying ASP Isotopes stock or one of its competitors? The main competitors of ASP Isotopes include Chemours (CC), Ingevity (NGVT), CVR Partners (UAN), Braskem (BAK), Ecovyst (ECVT), Tronox (TROX), Westlake Chemical Partners (WLKP), AdvanSix (ASIX), Orion (OEC), and Valhi (VHI). These companies are all part of the "chemicals" industry. ASP Isotopes vs. Its Competitors Chemours Ingevity CVR Partners Braskem Ecovyst Tronox Westlake Chemical Partners AdvanSix Orion Valhi Chemours (NYSE:CC) and ASP Isotopes (NASDAQ:ASPI) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations. Do institutionals & insiders believe in CC or ASPI? 76.3% of Chemours shares are held by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are held by institutional investors. 0.5% of Chemours shares are held by insiders. Comparatively, 21.4% of ASP Isotopes shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor CC or ASPI? In the previous week, Chemours had 13 more articles in the media than ASP Isotopes. MarketBeat recorded 19 mentions for Chemours and 6 mentions for ASP Isotopes. ASP Isotopes' average media sentiment score of 1.06 beat Chemours' score of 0.31 indicating that ASP Isotopes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral ASP Isotopes 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CC or ASPI? Chemours presently has a consensus target price of $17.33, indicating a potential upside of 25.51%. ASP Isotopes has a consensus target price of $6.67, indicating a potential downside of 11.35%. Given Chemours' higher possible upside, research analysts clearly believe Chemours is more favorable than ASP Isotopes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemours 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56ASP Isotopes 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CC or ASPI more profitable? Chemours has a net margin of 0.54% compared to ASP Isotopes' net margin of -767.86%. Chemours' return on equity of 23.82% beat ASP Isotopes' return on equity.Company Net Margins Return on Equity Return on Assets Chemours0.54% 23.82% 2.07% ASP Isotopes -767.86%-88.40%-41.80% Which has better valuation & earnings, CC or ASPI? Chemours has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemours$5.78B0.36$86M$0.2069.05ASP Isotopes$4.14M152.36-$32.33M-$0.61-12.33 Which has more risk and volatility, CC or ASPI? Chemours has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.35, suggesting that its stock price is 235% more volatile than the S&P 500. SummaryChemours beats ASP Isotopes on 11 of the 16 factors compared between the two stocks. Get ASP Isotopes News Delivered to You Automatically Sign up to receive the latest news and ratings for ASPI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASPI vs. The Competition Export to ExcelMetricASP IsotopesCHEM IndustryMaterials SectorNASDAQ ExchangeMarket Cap$630.74M$11.78B$3.29B$9.11BDividend YieldN/A3.35%5.14%4.01%P/E Ratio-12.3322.9192.7520.26Price / Sales152.364.7731,218,733,196,606,800.0099.74Price / CashN/A7.6423.8957.67Price / Book10.441.646.065.49Net Income-$32.33M$507.43M$147.90M$250.45M7 Day Performance8.28%2.82%2.30%4.79%1 Month Performance-10.05%5.65%6.57%7.68%1 Year Performance116.71%-4.92%26.88%16.44% ASP Isotopes Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASPIASP Isotopes0.8229 of 5 stars$7.52+1.1%$6.67-11.3%+111.2%$630.74M$4.14M-12.3376News CoverageCCChemours4.4405 of 5 stars$12.42-3.9%$17.33+39.6%-43.1%$1.86B$5.78B62.106,000News CoverageAnalyst RevisionNGVTIngevity3.3538 of 5 stars$45.40-2.9%$52.75+16.2%+9.1%$1.66B$1.41B-4.661,600News CoverageGap DownUANCVR Partners1.9997 of 5 stars$89.50+0.6%N/A+16.8%$1.53B$525.32M12.55300News CoveragePositive NewsBAKBraskem2.1439 of 5 stars$3.39-0.6%$9.75+187.6%-50.1%$1.35B$14.36B-0.818,382News CoverageECVTEcovyst3.0289 of 5 stars$8.66+3.1%$10.00+15.5%-6.8%$1.02B$706.15M-86.60880High Trading VolumeTROXTronox4.683 of 5 stars$5.24-6.1%$7.63+45.5%-65.6%$830.33M$3.07B-5.526,500Analyst ForecastGap DownWLKPWestlake Chemical Partners2.6022 of 5 stars$22.33-0.6%N/A-2.8%$786.91M$1.14B14.99150ASIXAdvanSix3.7929 of 5 stars$24.42-3.4%$33.50+37.2%-0.3%$654.70M$1.52B7.831,450News CoverageOECOrion4.4588 of 5 stars$10.79-4.1%$14.50+34.4%-49.5%$607.15M$1.88B23.461,658Positive NewsVHIValhi0.2931 of 5 stars$18.29+1.0%$12.00-34.4%+7.3%$517.61M$2.10B4.462,524High Trading Volume Related Companies and Tools Related Companies Chemours Alternatives Ingevity Alternatives CVR Partners Alternatives Braskem Alternatives Ecovyst Alternatives Tronox Alternatives Westlake Chemical Partners Alternatives AdvanSix Alternatives Orion Alternatives Valhi Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASPI) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASP Isotopes Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ASP Isotopes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
